Catalyst Clinical Research
Catalyst Clinical Research, LLC is a contract research organization based in Durham, North Carolina, specializing in providing staffing services and clinical operation solutions to biotechnology, pharmaceutical, and medical device companies. Established in 2013, the company leverages over two decades of industry experience to support clinical development programs with therapeutically-aligned professionals and customized solutions. Catalyst focuses on oncology and offers a range of clinical trial services, including multi-therapeutic resourcing and functional solutions. By simplifying clinical research data, the organization aims to accelerate critical trial decisions, particularly in early-phase studies, thereby facilitating the development of next-generation cancer therapies for patients.
Genpro Research
Acquisition in 2023
Genpro Research is a consulting firm specializing in the pharmaceutical, biotechnology, and medical device sectors. It offers expert services in biostatistics and programming, medical writing, and regulatory submissions. The company assists clients in navigating complex statistical issues during study design and analysis, with a particular focus on adaptive designs. Additionally, Genpro provides guidance on incorporating and analyzing the effectiveness of statistical methodologies in clinical trials, helping clients succeed throughout various business phases.
Aptus Clinical
Acquisition in 2022
Aptus Clinical is a specialized clinical contract research organization that provides comprehensive clinical research services. The company focuses on early phase clinical studies in areas such as oncology, cell and gene therapies, and rare diseases. Aptus Clinical offers a range of services including project management, site monitoring, data management, statistics, programming, and medical monitoring. By delivering these tailored solutions, Aptus Clinical assists life science companies in advancing their research and transforming innovative ideas into effective treatments, ultimately optimizing their clinical development processes.
Ce3 Inc. is an oncology contract research organization based in Clinton, Connecticut, that specializes in early-phase clinical development services for the biotechnology sector. Founded in 2005, the company focuses on novel therapeutic modalities, including immuno-oncology and gene therapies, to support the development of innovative cancer treatments. Ce3 aims to understand the specific needs of biotechnology companies, offering high-quality and cost-effective solutions that align with their analytical, regulatory, and investor objectives. As of August 2020, Ce3 operates as a subsidiary of Catalyst Clinical Research, LLC.
Triangle Biostatistics
Acquisition in 2019
Triangle Biostatistics is a pharmaceutical company that offers specialized biostatistics and statistical programming services. It provides comprehensive statistical consulting and data management solutions, catering primarily to the pharmaceutical, biotechnology, and medical device industries. The company is committed to delivering innovative biometric solutions grounded in sound scientific principles and supported by advanced computing technology. Through its expertise, Triangle Biostatistics aims to enhance the quality and reliability of data analysis in clinical research and development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.